Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jason K Perry

12PUBLICATIONS
71CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCondensed matter characterisation technique developmentGene and molecular therapyProteins and peptidesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

Sort by Publication Date:
|Jan 07, 2026
Lenacapavir treatment-emergent HIV-1 capsid resistance mutations are frequently associated with replication defects.

Nina Pennetzdorfer, Vidula Naik, Sally Demirdjian

|Oct 08, 2025
A structural roadmap for the formation of the coronavirus nsp3/nsp4 double membrane vesicle pore and its implications for polyprotein processing and replication/transcription.

Jason K Perry, Samuel Itskanov, John P Bilello

|Oct 01, 2025
Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure Prophylaxis.

Eda Canales, Winston Tse, Scott D Schroeder

|Jul 17, 2024
Discovery of GS-7682, a Novel 4'-Cyano-Modified <i>C</i>-Nucleoside Prodrug with Broad Activity against Pneumo- and Picornaviruses and Efficacy in RSV-Infected African Green Monkeys.

Dustin S Siegel, Hon C Hui, Jared Pitts

|May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses.

David R Martinez, Fernando R Moreira, Nicholas J Catanzaro

|Apr 27, 2024
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials.

Charlotte Hedskog, Christoph D Spinner, Ulrike Protzer

Pageof 2

Frequent Collaborators

3 joint publications

John P Bilello

3 joint publications

Joy Y Feng

2 joint publications

Egor P Tchesnokov

2 joint publications

Timothy P Sheahan

2 joint publications

Richard L Mackman

2 joint publications

Brandon Malone

2 joint publications

Ed T Eng

2 joint publications

Seth A Darst

2 joint publications

Calvin J Gordon

2 joint publications

Hery W Lee

Frequent Collaborators

3 joint publications

John P Bilello

3 joint publications

Joy Y Feng

2 joint publications

Egor P Tchesnokov

2 joint publications

Timothy P Sheahan

Top Related Videos

A Restriction Enzyme Based Cloning Method to Assess the <em>In vitro</em> Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the <em>In vitro</em> Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on : Aug 31, 2014

16.1K
Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
09:08

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus

Published on : Jul 27, 2021

4.1K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

2.2K
See more related videos

Top Related Videos

A Restriction Enzyme Based Cloning Method to Assess the <em>In vitro</em> Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the <em>In vitro</em> Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on : Aug 31, 2014

16.1K
Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
09:08

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus

Published on : Jul 27, 2021

4.1K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

2.2K
See more related videos